Use of gene therapy in central nervous system repair (Q35599603)

9 August 2017

1 reference

title

Use of gene therapy in central nervous system repair (English)

1 reference

9 August 2017

0 references

Tinsley R

1 reference

9 August 2017

Eriksson P

series ordinal

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

Acta Neurologica Scandinavica

9 August 2017

published in

1 reference

9 August 2017

volume

109

1 reference

9 August 2017

1 reference

9 August 2017

page(s)

1-8

1 reference

Antisense strategies in neurobiology

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-0404.2003.00240.X

Rational design and engineering of therapeutic proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-0404.2003.00240.X

New approaches to rational drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-0404.2003.00240.X

Gene therapy for acute diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-0404.2003.00240.X

The glial scar and central nervous system repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-0404.2003.00240.X

Neurotrophin-3 enhances sprouting of corticospinal tract during development and after adult spinal cord lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-0404.2003.00240.X

Stimulation of corticospinal tract regeneration in the chronically injured spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-0404.2003.00240.X

Spinal cord regeneration: from gene to transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-0404.2003.00240.X

Neurotrophins Prevent Death and Differentially Affect Tyrosine Hydroxylase of Adult Rat Nigrostriatal Neuronsin Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-0404.2003.00240.X

Neurotrophic factors, gene therapy, and neural stem cells for spinal cord repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-0404.2003.00240.X

Schwann cells genetically modified to secrete human BDNF promote enhanced axonal regrowth across transected adult rat spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-0404.2003.00240.X

Neurotrophins: roles in neuronal development and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-0404.2003.00240.X

Neurotrophic factors and gene therapy in spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-0404.2003.00240.X

Brain ischemia as a potential target of gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-0404.2003.00240.X

Gene transfer of hepatocyte growth factor to subarachnoid space in cerebral hypoperfusion model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-0404.2003.00240.X

Therapeutic time window of adenovirus-mediated GDNF gene transfer after transient middle cerebral artery occlusion in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-0404.2003.00240.X

Growth in paediatric Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-0404.2003.00240.X

Application of ex vivo gene therapy in the treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-0404.2003.00240.X

Conditioned medium from aged monkey fibroblasts stably expressing GDNF and BDNF improves survival of embryonic dopamine neurons in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-0404.2003.00240.X

The effects of storage conditions and trophic supplementation on the survival of fetal mesencephalic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-0404.2003.00240.X

Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-0404.2003.00240.X

Recombinant adeno-associated viral vector-mediated glial cell line-derived neurotrophic factor gene transfer protects nigral dopamine neurons after onset of progressive degeneration in a rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-0404.2003.00240.X

Therapeutic effects of astrocytes expressing both tyrosine hydroxylase and brain-derived neurotrophic factor on a rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-0404.2003.00240.X

Alleviation of behavioral deficits in aged rodents following implantation of encapsulated GDNF-producing fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-0404.2003.00240.X

Viral vectors for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-0404.2003.00240.X

Cytotoxicity issues pertinent to lipoplex-mediated gene therapy in-vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-0404.2003.00240.X

Practical aspects of the development of ex vivo and in vivo gene therapy for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-0404.2003.00240.X

Cell therapy in Parkinson's disease - stop or go?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-0404.2003.00240.X

Transplantation of human adult astrocytes: efficiency and safety requirements for an autologous gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-0404.2003.00240.X

The injured brain interacts reciprocally with neural stem cells supported by scaffolds to reconstitute lost tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-0404.2003.00240.X

Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-0404.2003.00240.X

Neural stem cells spontaneously express dopaminergic traits after transplantation into the intact or 6-hydroxydopamine-lesioned rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-0404.2003.00240.X

Neurospheres modified to produce glial cell line-derived neurotrophic factor increase the survival of transplanted dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-0404.2003.00240.X

Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-0404.2003.00240.X

Long-term striatal overexpression of GDNF selectively downregulates tyrosine hydroxylase in the intact nigrostriatal dopamine system

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-0404.2003.00240.X

Progress in spinal cord research - a refined strategy for the International Spinal Research Trust

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-0404.2003.00240.X

Reduced BDNF mRNA Expression in the Parkinson's Disease Substantia Nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-0404.2003.00240.X

21 January 2018

In search of a miracle

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-0404.2003.00240.X

10.1046/J.1600-0404.2003.00240.X

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference